General Information of the Compound
Compound ID |
CP0232834
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
5-BENZYLOXYTRYPTAMINE
Show/Hide
|
||||||||||||||||||
Synonyms |
1H-Indole-3-ethanamine, 5-(phenylmethoxy)-
1H-Indole-3-ethanamine,5-(phenylmethoxy)-
2-(5-(Benzyloxy)-1H-indol-3-yl)ethanamine
2-(5-Benzyloxy-1H-indol-3-yl)-ethylamine
2-[5-(benzyloxy)-1H-indol-3-yl]ethanamine
2-[5-(benzyloxy)-1H-indol-3-yl]ethanamine hydrochloride
2-[5-(phenylmethoxy)indol-3-yl]ethylamine
20776-45-8
3-(2-aminoethyl)-5-benzyloxyindole
5-BT
5-Benzyloxy-3-(2-ethylamino)indole hydrochloride
5-Benzyloxytriptamine
5-Benzyloxytryptamine
B-2100
CHEMBL1288652
EINECS 244-
WKPDXBXNJWWWGQ-UHFFFAOYSA-N
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H18N2O
|
||||||||||||||||||
Molecular Weight |
266.344
|
||||||||||||||||||
Canonical SMILES |
NCCc1c[nH]c2ccc(OCc3ccccc3)cc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H18N2O/c18-9-8-14-11-19-17-7-6-15(10-16(14)17)20-12-13-4-2-1-3-5-13/h1-7,10-11,19H,8-9,12,18H2
Show/Hide
|
||||||||||||||||||
InChIKey |
WKPDXBXNJWWWGQ-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
20776-45-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT03065, Transient receptor potential cation channel subfamily M member 8
Clinical Information about the Compound